Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency.

Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency. Abstract Text:

Multiple carboxylase deficiency is a clinical condition caused by defects in the enzymes involved in biotin metabolism, holocarboxylase synthetase (HLCS) or biotinidase. HLCS deficiency is a potentially fatal condition if left untreated, although the majority of patients respond to oral supplementation of 10-20 mg/day of biotin. Patients who display incomplete responsiveness to this therapy have a poor long-term prognosis. Here we investigated cell lines from two such HLCS-deficient patients homozygous for the c.647T>G p.L216R allele. Growth of the patients' fibroblasts was compromised compared with normal fibroblasts. Also the patient cells were not sensitive to biotin-depletion from the media, and growth rates could not be restored by re-administration of biotin. The molecular basis for the HLCS deficiency was further investigated by characterisation of the p.L216R protein. The HLCS mRNA was detected in MCD and normal cell lines. However, protein and enzyme activity could not be detected in the patients' cells. In vitro kinetic analysis revealed that enzyme activity was severely compromised for recombinantly expressed p.L216R and could not be increased by additional biotin. Furthermore, the turn-over rate for the mutant protein was double that of wildtype HLCS. These results help provide a molecular explanation for the incomplete biotin-responsiveness of this p.L216R form of HLCS.

Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Human mutation

VOLUME: 29

Page Numbers: E47-57

Journal Abbreviation: Hum. Mutat.

ISSN: 1098-1004

DAY: 28

MONTH: Jun

YEAR: 2008

Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9215429

Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency.

AFFILIATION: School of Molecular and Biomedical Science, The University of Adelaide, Adelaide, South Australia 5005, Australia.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hum Mutat

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency Related Publications

• Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion.
• Artifactual detection of biotin on histones by streptavidin.
• Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol.
• Breast cancer stem cells: a case of mistaken identity?
• Breast cancer: origins and evolution.
• Breast tumor heterogeneity: cancer stem cells or clonal evolution?
• Cell type-specific DNA methylation patterns in the human breast.
• Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression.
• FMC7 is an epitope of CD20.
• Is breast tumor progression really linear?
• Methylation-specific digital karyotyping.
• Microbial biotin protein ligases aid in understanding holocarboxylase synthetase deficiency.
• Microenvironmental regulation of cancer development.
• Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency.
• Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection.
• Regulation of in situ to invasive breast carcinoma transition.
• The cancer stem cell hypothesis: in search of definitions, markers, and relevance.
• [Daily variation in intraocular pressure.]